Qiming closes China’s largest venture capital renminbi fund for 2023 at 6.5 billion yuan

Published Thu, May 18, 2023 · 04:36 PM
    • The latest close brings Qiming’s total capital raised to US$9.5 billion across 18 funds, focusing on investments in early and growth stage firms in the technology, consumer and healthcare sectors
    • The latest close brings Qiming’s total capital raised to US$9.5 billion across 18 funds, focusing on investments in early and growth stage firms in the technology, consumer and healthcare sectors PHOTO: QIMING

    DeeperDive is a beta AI feature. Refer to full articles for the facts.

    CHINA’S Qiming Venture Partners on Thursday (May 18) said it had closed its seventh renminbi fund at 6.5 billion yuan (S$1.2 billion), in what it said is the largest renminbi fundraising in China’s venture capital market this year.

    The latest close brings Qiming’s total capital raised to US$9.5 billion across 18 funds, focusing on investments in early and growth stage firms in the technology, consumer and healthcare sectors, it said in a statement.

    Qiming, an early backer of tech giants such as Meituan and Xiaomi, said the fund drew strong participation from its existing investor base, including insurance companies and public listed companies.

    Qiming made 90 investments last year, which included OriCell Therapeutics and ArkBio, according to the statement.

    Founded in 2006, Qiming has over 530 portfolio companies as of May this year, according to its website. REUTERS

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    Copyright SPH Media. All rights reserved.